KLK14 Activators encompasses a group of compounds and substances that are known to modulate or stimulate the activity of the kallikrein-related peptidase 14 (KLK14) enzyme. KLK14, a member of the KLK family, is a serine protease with diverse physiological roles, including involvement in skin biology and tissue remodeling, and its activation or regulation is of interest in various research contexts. These activators interact with KLK14 through a range of mechanisms, either directly or indirectly, and are utilized primarily in experimental and investigative settings to study the enzyme's functions and regulatory pathways.
KLK14 activators can be categorized into two broad groups: direct and indirect activators. Direct activators are those that directly bind to and modify the enzymatic activity of KLK14, promoting its proteolytic functions. These may include small molecules or peptides designed to enhance the catalytic efficiency of the enzyme. On the other hand, indirect activators influence KLK14 activity by targeting upstream or downstream components of signaling pathways that converge on the enzyme. These compounds can alter the expression or post-translational modifications of KLK14, ultimately impacting its function. In both cases, the aim is to gain a better understanding of KLK14's role in various biological processes, such as skin desquamation and potential contributions to disease states, by manipulating its activity. The study of KLK14 activators contributes to the broader field of enzymology and protease biology, shedding light on the intricate regulatory networks that govern this protease's function in different physiological and pathological contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
A retinoid compound that activates KLK14 expression by modulating gene regulatory mechanisms and cellular differentiation. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A protein kinase inhibitor that indirectly triggers KLK14 activation through modulation of downstream signaling pathways. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor that indirectly initiates KLK14 activation by modifying chromatin structure and gene activation mechanisms. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that can indirectly activate KLK14 expression by influencing epigenetic activation mechanisms, including DNA methylation. | ||||||
Aprotinin | 9087-70-1 | sc-3595 sc-3595A sc-3595B | 10 mg 100 mg 1 g | $112.00 $408.00 $3000.00 | 51 | |
A protease inhibitor that indirectly modulates serine protease activity, potentially activating KLK14 through the enzymatic mechanisms it targets, including serine proteases like KLK14. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
An activator of protein kinase C (PKC) that indirectly initiates KLK14 activation by interacting with PKC signaling pathways and related cellular processes. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
A histone deacetylase inhibitor that indirectly activates KLK14 by modifying chromatin structure and gene activation mechanisms, potentially impacting KLK14 expression. | ||||||